Trials / Completed
CompletedNCT00670033
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
Comparison of Safety and IOP-Lowering Efficacy of Three Alternative Travoprost Formulations to Vehicle and TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to describe the safety and IOP-lowering efficacy of Travoprost New Formulations compared to TRAVATAN® and to vehicle in patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost ophthalmic solution (new formulation) | |
| DRUG | Travoprost ophthalmic solution, 0.004% | |
| DRUG | Vehicle | Inactive ingredients used as a placebo |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2008-05-01
- Last updated
- 2014-07-10
Source: ClinicalTrials.gov record NCT00670033. Inclusion in this directory is not an endorsement.